+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Animal Stem Cell Therapy Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994257
UP TO OFF until Nov 15th 2024
The animal stem cell therapy market was valued at $256.0 million in 2023 and is projected to reach $440.0 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Animal stem cell therapy is a procedure which involves the usage of stem cells to treat injuries or cure diseases in animals. Stem cells are the undifferentiated cells inside a living body which possess the capacity to give rise to new cells with different functionalities. This ability of stem cells makes them essential for the repair of damaged tissues and organs. To perform the therapy, the stem cells are harvested from diverse body parts, including bone marrow, umbilical cord blood, or fat tissue. The therapy has proven to be beneficial in the treatment of different conditions such as osteoarthritis, neurological disorders, tendon & ligament injuries, and various autoimmune diseases.

Increase in the ownership of pets globally, along with surge in expenditure on their lifestyle and health is a key driver of the animal stem cell therapy market. In addition, prevalence of chronic diseases and health-related disorders is rising among animals, thereby boosting the demand for stem cell therapy. With progressing technology, the trend of integrating AI in stem cell therapy is gaining prominence. AI is proving to be an unprecedented tool for achieving precision and addressing complications during the treatment. The tool helps to design a reliable framework for different procedures, including classification of stem cells colony, identification of cellular morphology, characterization of undescribed morphological traits in cancer stem cells, and prediction of drug effects.

However, the costs of animal stem cell therapies are significantly high, restricting the pet owners with limited budgets from affording such treatments. In addition, the market development is hampered by the ethical considerations surrounding the utility of stem cells, as compliance with such regulations is an intricate and lengthy procedure. For instance, the European Medicines Agency has implemented a rigorous evaluation process pertaining to stem cell therapies for veterinary use.

Segment Review

The animal stem cell therapy market is segmented into type, species, end user, and region. On the basis of type, the market is bifurcated into allogenic and autologous. As per species, it is divided into dog, cat, and horse. Depending on end user, it is classified into veterinary hospitals and research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the allogenic segment accounted for the highest market share in 2023.

As per species, the dog segment acquired high stakes in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global animal stem cell therapy market include Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics, Boehringer Ingelheim, Cell Therapy Sciences, VETherapy Corporation, and MediVet Biologics LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Allogenic
  • Autologous

By Species

  • Dog
  • Cat
  • Horse

By End User

  • Veterinary Hospitals
  • Research Organizations

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
Key Market Players
  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Regeneus Ltd.
  • Magellan Stem Cells
  • PrimeGen Biotech, LLC
  • Vetbiologics
  • Boehringer Ingelheim
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Allogenic
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Autologous
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY SPECIES
5.1. Market Overview
5.1.1 Market Size and Forecast, By Species
5.2. Dog
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cat
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Horse
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Veterinary Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research Organizations
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
CHAPTER 7: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Species
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Species
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Species
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Species
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Species
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Species
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Species
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Species
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Species
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Species
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Species
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Species
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Species
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Species
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Species
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Species
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Species
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Species
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Species
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Species
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Species
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Species
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Species
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Aratana Therapeutics, Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. VetStem, Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Regeneus Ltd.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Magellan Stem Cells
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. PrimeGen Biotech, LLC
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Vetbiologics
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Boehringer Ingelheim
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Cell Therapy Sciences
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. VETherapy Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. MediVet Biologics LLC
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 2. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Allogenic, by Region, 2024 - 2033 ($Million)
Table 3. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Autologous, by Region, 2024 - 2033 ($Million)
Table 4. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 5. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Dog, by Region, 2024 - 2033 ($Million)
Table 6. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Cat, by Region, 2024 - 2033 ($Million)
Table 7. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Horse, by Region, 2024 - 2033 ($Million)
Table 8. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 9. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Veterinary Hospitals, by Region, 2024 - 2033 ($Million)
Table 10. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Research Organizations, by Region, 2024 - 2033 ($Million)
Table 11. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Region, 2024 - 2033 ($Million)
Table 12. North America Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Country, 2024 - 2033 ($Million)
Table 13. North America Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 14. North America Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 15. North America Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 16. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 17. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 18. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 19. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 20. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 21. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 22. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 23. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 24. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 25. Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Country, 2024 - 2033 ($Million)
Table 26. Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 27. Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 28. Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 29. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 30. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 31. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 32. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 33. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 34. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 35. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 36. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 37. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 38. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 39. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 40. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 41. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 42. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 43. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 44. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 45. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 46. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 47. Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Country, 2024 - 2033 ($Million)
Table 48. Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 49. Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 50. Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 51. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 52. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 53. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 54. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 55. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 56. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 57. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 58. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 59. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 60. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 61. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 62. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 63. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 64. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 65. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 66. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 67. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 68. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 69. LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Country, 2024 - 2033 ($Million)
Table 70. LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 71. LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 72. LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 73. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 74. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 75. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 76. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 77. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 78. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 79. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 80. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 81. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 82. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Type, 2024 - 2033 ($Million)
Table 83. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by Species, 2024 - 2033 ($Million)
Table 84. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, by End-user, 2024 - 2033 ($Million)
Table 85. Aratana Therapeutics, Inc.: Key Executives
Table 86. Aratana Therapeutics, Inc.: Company Snapshot
Table 87. Aratana Therapeutics, Inc.: Operating Segments
Table 88. Aratana Therapeutics, Inc.: Product Portfolio
Table 89. Aratana Therapeutics, Inc.: Key Strategic Moves and Developments
Table 90. Vetstem, Inc.: Key Executives
Table 91. Vetstem, Inc.: Company Snapshot
Table 92. Vetstem, Inc.: Operating Segments
Table 93. Vetstem, Inc.: Product Portfolio
Table 94. Vetstem, Inc.: Key Strategic Moves and Developments
Table 95. Regeneus Ltd.: Key Executives
Table 96. Regeneus Ltd.: Company Snapshot
Table 97. Regeneus Ltd.: Operating Segments
Table 98. Regeneus Ltd.: Product Portfolio
Table 99. Regeneus Ltd.: Key Strategic Moves and Developments
Table 100. Magellan Stem Cells: Key Executives
Table 101. Magellan Stem Cells: Company Snapshot
Table 102. Magellan Stem Cells: Operating Segments
Table 103. Magellan Stem Cells: Product Portfolio
Table 104. Magellan Stem Cells: Key Strategic Moves and Developments
Table 105. Primegen Biotech, LLC: Key Executives
Table 106. Primegen Biotech, LLC: Company Snapshot
Table 107. Primegen Biotech, LLC: Operating Segments
Table 108. Primegen Biotech, LLC: Product Portfolio
Table 109. Primegen Biotech, LLC: Key Strategic Moves and Developments
Table 110. Vetbiologics: Key Executives
Table 111. Vetbiologics: Company Snapshot
Table 112. Vetbiologics: Operating Segments
Table 113. Vetbiologics: Product Portfolio
Table 114. Vetbiologics: Key Strategic Moves and Developments
Table 115. Boehringer Ingelheim: Key Executives
Table 116. Boehringer Ingelheim: Company Snapshot
Table 117. Boehringer Ingelheim: Operating Segments
Table 118. Boehringer Ingelheim: Product Portfolio
Table 119. Boehringer Ingelheim: Key Strategic Moves and Developments
Table 120. Cell Therapy Sciences: Key Executives
Table 121. Cell Therapy Sciences: Company Snapshot
Table 122. Cell Therapy Sciences: Operating Segments
Table 123. Cell Therapy Sciences: Product Portfolio
Table 124. Cell Therapy Sciences: Key Strategic Moves and Developments
Table 125. Vetherapy Corporation: Key Executives
Table 126. Vetherapy Corporation: Company Snapshot
Table 127. Vetherapy Corporation: Operating Segments
Table 128. Vetherapy Corporation: Product Portfolio
Table 129. Vetherapy Corporation: Key Strategic Moves and Developments
Table 130. Medivet Biologics LLC: Key Executives
Table 131. Medivet Biologics LLC: Company Snapshot
Table 132. Medivet Biologics LLC: Operating Segments
Table 133. Medivet Biologics LLC: Product Portfolio
Table 134. Medivet Biologics LLC: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, 2024 - 2033
Figure 2. Segmentation of Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market, 2024 - 2033
Figure 3. Top Investment Pocket in Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalanimal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
Figure 10. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market Segmentation, by Type
Figure 11. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Allogenic, by Country, 2024 - 2033 ($Million)
Figure 12. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Autologous, by Country, 2024 - 2033 ($Million)
Figure 13. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market Segmentation, by Species
Figure 14. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Dog, by Country, 2024 - 2033 ($Million)
Figure 15. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Cat, by Country, 2024 - 2033 ($Million)
Figure 16. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Horse, by Country, 2024 - 2033 ($Million)
Figure 17. Global Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market Segmentation, by End-user
Figure 18. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Veterinary Hospitals, by Country, 2024 - 2033 ($Million)
Figure 19. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market for Research Organizations, by Country, 2024 - 2033 ($Million)
Figure 20. Top Winning Strategies, by Year, 2021-2023*
Figure 21. Top Winning Strategies, by Development, 2021-2023*
Figure 22. Top Winning Strategies, by Company, 2021-2023*
Figure 23. Product Mapping of Top 10 Players
Figure 24. Competitive Dashboard
Figure 25. Competitive Heatmap: Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End-user (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
Figure 26. Top Player Positioning, 2023
Figure 27. Aratana Therapeutics, Inc.: Net Sales, 2021-2023 ($Million)
Figure 28. Aratana Therapeutics, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 29. Aratana Therapeutics, Inc.: Revenue Share, by Region, 2023 (%)
Figure 30. Vetstem, Inc.: Net Sales, 2021-2023 ($Million)
Figure 31. Vetstem, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 32. Vetstem, Inc.: Revenue Share, by Region, 2023 (%)
Figure 33. Regeneus Ltd.: Net Sales, 2021-2023 ($Million)
Figure 34. Regeneus Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 35. Regeneus Ltd.: Revenue Share, by Region, 2023 (%)
Figure 36. Magellan Stem Cells: Net Sales, 2021-2023 ($Million)
Figure 37. Magellan Stem Cells: Revenue Share, by Segment, 2023 (%)
Figure 38. Magellan Stem Cells: Revenue Share, by Region, 2023 (%)
Figure 39. Primegen Biotech, LLC: Net Sales, 2021-2023 ($Million)
Figure 40. Primegen Biotech, LLC: Revenue Share, by Segment, 2023 (%)
Figure 41. Primegen Biotech, LLC: Revenue Share, by Region, 2023 (%)
Figure 42. Vetbiologics: Net Sales, 2021-2023 ($Million)
Figure 43. Vetbiologics: Revenue Share, by Segment, 2023 (%)
Figure 44. Vetbiologics: Revenue Share, by Region, 2023 (%)
Figure 45. Boehringer Ingelheim: Net Sales, 2021-2023 ($Million)
Figure 46. Boehringer Ingelheim: Revenue Share, by Segment, 2023 (%)
Figure 47. Boehringer Ingelheim: Revenue Share, by Region, 2023 (%)
Figure 48. Cell Therapy Sciences: Net Sales, 2021-2023 ($Million)
Figure 49. Cell Therapy Sciences: Revenue Share, by Segment, 2023 (%)
Figure 50. Cell Therapy Sciences: Revenue Share, by Region, 2023 (%)
Figure 51. Vetherapy Corporation: Net Sales, 2021-2023 ($Million)
Figure 52. Vetherapy Corporation: Revenue Share, by Segment, 2023 (%)
Figure 53. Vetherapy Corporation: Revenue Share, by Region, 2023 (%)
Figure 54. Medivet Biologics LLC: Net Sales, 2021-2023 ($Million)
Figure 55. Medivet Biologics LLC: Revenue Share, by Segment, 2023 (%)
Figure 56. Medivet Biologics LLC: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Animal Stem Cell Therapy Market include:
  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Regeneus Ltd.
  • Magellan Stem Cells
  • PrimeGen Biotech, LLC
  • Vetbiologics
  • Boehringer Ingelheim
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information